
JNJ - Johnson & Johnson
Annual data, 1996 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Capital
Dividend
Revenue
Income
Asset
Equity
Rolling CAGR% per year, window ending each year
Other companies

Merck
Data since 1996

Amgen
Data since 1996

AbbVie
Data since 2010

Roche
Data since 1998

Novartis
Data since 1998

AstraZeneca
Data since 1996

Eli Lilly
Data since 1996
Gilead Sciences
Data since 1996
Novo Nordisk
Data since 1996
Pfizer
Data since 1996
Vertex Pharmaceuticals
Data since 1996
Bristol-Myers Squibb
Data since 1996
Sanofi
Data since 2001
GSK plc
Data since 1996
WuXi AppTec
Data since 2014
Moderna
Data since 2016
Regeneron Pharmaceuticals
Data since 1996

Thermo Fisher Scientific
Data since 1996
CVS Health
Data since 1996

Visa
Data since 2003

Cisco
Data since 1996

Walmart
Data since 1996

Chevron
Data since 1996

Caterpillar
Data since 1996

Coca-Cola
Data since 1996

JPMorgan Chase
Data since 1996

Procter & Gamble
Data since 1996

UnitedHealth
Data since 1996

Home Depot
Data since 1996

Goldman Sachs
Data since 1999
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Rolling CAGR needs positive values at both ends of the window. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown.